MedPath

Clinical Study of Hydrophilic, Hydrophobic and PMMA intraocular lenses

Phase 3
Conditions
Health Condition 1: H590- Disorders of the eye following cataract surgery
Registration Number
CTRI/2021/11/038257
Lead Sponsor
Ophthalmic Marketing and Services Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adult

-Subjects who have already undergone cataract surgery using IOL

-Calculated IOL power is within the range of the investigational IOL (+ 6.0 to 35.0 Diopter)

-Subjects available after contact and willing to come for follow up during the clinical study.

-Subjects with signed informed consent

Subject having clear intraocular media other than cataract

Exclusion Criteria

-Patients unwilling to participate in the study

-Subject with previous intraocular or corneal surgery

-Subject having traumatic cataract

-Pregnancy or lactation

-Concurrent participation in another drug or device investigation

-Instability of keratometry or biometry measurements

-Irregular astigmatism

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the intraoperative Safety and Performance of the IOLTimepoint: one year
Secondary Outcome Measures
NameTimeMethod
To determine the presence of lens related adverse events/residual risks and the visual acuity in the individuals on whom the device was implanted.Timepoint: 1 Year
© Copyright 2025. All Rights Reserved by MedPath